How Cell and Gene Therapy Manufacturing is transforming Life Sciences with Jason Bock

Transformation in Trials

What if a pharmaceutical company can be deconstructed and re-assembled in a new configuration? This is already happening in cell and gene therapy manufacturing. Join us for an enlightening conversation with Jason Bock, the founder and CEO of CTMC, who has been at the forefront of this intersection between clinical research and manufacturing. Discover the unique challenges of setting up a manufacturing network for autologous cell therapies and how this relationship between clinical and manufacturing sites differs from traditional methods. Jason shares his journey of moving to MD Anderson Cancer Center, setting up a biotech firm, and transforming the supply chain, thereby expediting product development.
Imagine the thrill of cell therapy advancements and the potential for cures in a single dose! Uncover how the trailblazing minds at CTMC and MD Anderson have submitted six INDs in the span of just 18 months. Half of these are MD Anderson invented therapies, while the rest are biotech invented products. Alongside these exciting developments, we also delve into the implications of such revolutionary treatments on the healthcare system. Understand the challenges that lay ahead in terms of making these potentially curative treatments widely accessible. Tune in for this riveting discussion on the transformation of healthcare, offering a glimpse into the future of medicine.
Guest:
Jason Bock

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

Hoofdstukken

1. How Cell and Gene Therapy Manufacturing is transforming Life Sciences with Jason Bock (00:00:00)

2. Manufacturing Clinical Research in Cell Therapies (00:00:21)

3. Cell Therapy Advancements and Manufacturing (00:20:56)